Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Symbiosis secures FDA viral vector process approval

    Sep 27, 2018, 06:11 AM by Michael Croft
    NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 27, 2018 - Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK
    Full story
  • Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs

    Sep 27, 2018, 05:40 AM by Michael Croft
    MOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro  cardiac safety evaluation of new drugs
    Full story
  • Equus, Thermo Fisher Scientific, NVIDIA, And More: News From September 2018

    Sep 26, 2018, 12:55 PM by Michael Croft

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Equus, Thermo Fisher Scientific, NVIDIA, and more.

    Full story
  • Thermo Fisher Scientific Expands Genome Editing IP Portfolio

    Sep 26, 2018, 11:04 AM by Michael Croft
    CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio
    Full story
  • NIH-Funded Genome Centers To Accelerate Precision Medicine Discoveries

    Sep 26, 2018, 10:00 AM by Michael Croft

    Bio-IT World News Brief | The All of Us Research Program awarded funds totaling $28.6 million to establish three genome centers around the country.

    Full story
  • Qlucore AB announces changes to Board of Directors

    Sep 26, 2018, 09:54 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at Ericsson
    Full story
  • Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care

    Sep 26, 2018, 08:16 AM by Michael Croft
    PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients
    Full story
  • LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare

    Sep 25, 2018, 11:04 AM by Michael Croft
    CAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 -  Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reports
    Full story
  • Quanticate partners with CluePoints™ to offer Data Quality Oversight

    Sep 25, 2018, 04:31 AM by Michael Croft
    LONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the  amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines
    Full story
  • BioIVT to Host the 2018 HEPATOPAC® User Group Meeting in Boston

    Sep 24, 2018, 13:04 PM by Michael Croft
    WESTBURY, NY, US - Sep 24, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be hosting the 2018 HEPATOPAC User Group Meeting (UGM) from 8:30 a
    Full story
  • A $100 Million Biotech Deal Is Also A Tale Of Two Executives Facing Their Kids Deadly Diseases

    Sep 21, 2018, 14:42 PM by Michael Croft
    Forbes | Amicus Therapertics is purchasing a portfolio of ten gene therapies for $100 million. But there's more to this story than most business deals.
    Full story
  • Canines-N-Kids Foundation To Host Symposium, Aims To Accelerate Drug Development For Child, Dog Cancers

    Sep 21, 2018, 13:40 PM by Michael Croft

    Bio-IT World News Brief | Canines-N-Kids Foundation is hosting the Paws for a Cure Research Symposium this November at the Merck Research Laboratories in Boston. The Foundation hopes to examine challenges and progress in accelerating cancer drug development for cancers shared between children and dogs.

    Full story
  • H1 Launches “Strategy As A Service” Offering, Helps Life Sciences Companies Cut Time-To-Market In Half

    Sep 21, 2018, 12:35 PM by Michael Croft

    Bio-IT World News Brief | H1 launched a new Strategy as a Service offering designed to help clients accelerate the market research phase of drug development.

    Full story
  • Cray Picks Up Two Supercomputer Wins In Asia

    Sep 21, 2018, 07:22 AM by Michael Croft
    TOP500 | Cray has announced two new XC50 supercomputers that were purchased by research organizations in Japan and South Korea.
    Full story
  • ABclonal Technology Unveils Next-Generation Sequencing Kits For Illumina Sequencing Platforms

    Sep 20, 2018, 16:01 PM by Michael Croft
    BOSTON, MA, UNITED STATES - Sep 13, 2018 - ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation sequencing library preparation kits (NGS lib prep kits), one of the industry’s highest-yielding DNA and RNA library preparation kits
    Full story
  • H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half

    Sep 20, 2018, 13:50 PM by Michael Croft
    NEW YORK CITY, NY, US - Sep 20, 2018 -  FOR IMMEDIATE RELEASE Media contact:Michelle Faulkner
    +1 617-510-6998
    michelle@big-swing
    Full story
  • Oxford Genetics extends its CRISPR Gene Editing Technology License Agreement from ERS Genomics to support its growth internationally

    Sep 20, 2018, 08:34 AM by Michael Croft
    NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 20, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technology
    Full story
  • Domainex appoints Dr Trevor Perrior as Chief Executive Officer

    Sep 20, 2018, 06:07 AM by Michael Croft
    CAMBRIDGE, UK - Sep 20, 2018 - Domainex Ltd, a privately-owned drug research services company, is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018
    Full story
  • Novel deep learning drug discovery platform gets £1 million innovation boost

    Sep 19, 2018, 04:39 AM by Michael Croft
    , UK - Sep 19, 2018 - Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project
    Full story
  • Rho Recruiting New Team Members at SOCRA Annual Conference

    Sep 18, 2018, 14:52 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Sep 18, 2018 - WHAT:                 Rho, a full-service contract research organization (CRO), is hiring for a variety of clinical research positions, including clinical research associates (CRAs) and project managers, and will be looking to meet potential applicants during the upcoming Society of Clinical Research Associates (SOCRA) Annual Conference in New Orleans, Louisiana, September 28-30, 2018
    Full story
  • «
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259 (current)
  • 260
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy